Bloodpac
Membership Organizations · 11-50 Employees
View Company Info for Free
Overview
Website
www.bloodpac.orgRevenue
$6.4 MillionIndustry
About Bloodpac
Bloodpac Org Chart
Is Bloodpac your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Bloodpac, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Bloodpac had a recent Job posting/layoffs
Check out if Bloodpac is spiking on competitors!
Earning: See what the market has to say on Bloodpac recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Bloodpac
Product Launch: Get notified when Bloodpac launches new products
Funding: Get notified immidiatlly once Bloodpac has new funding data
Check if Bloodpac has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Bloodpac
Compare insights from companies similar to Bloodpac, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bloodpac is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Bloodpac is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Bloodpac.
Bloodpac Tech Stack
A closer look at the technologies used by Bloodpac
Bloodpac News & Media
BLOODPAC Publishes New Standards for Liquid Biopsy Tests That Monitor for Cancer Recurrence
Published in JCO Precision Oncology, the new analytical validation standards offer an industry-wide protocol for test developers CHICAGO, Jan. 15, 2026 /PRNewswire/ -- A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium was published in JCO...BLOODPAC's Inaugural Summit to Address the State of the Science on Liquid Biopsy and Priorities for the Next Five Years
Members will discuss goals for supporting expanding analytical and clinical validation as well as challenges in access and navigating global regulatory frameworks CHICAGO, March 29, 2022 /PRNewswire/ -- The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium will host a virtual liquid...BloodPAC Publishes FDA-Reviewed Validation Protocols for Liquid Biopsy
CHICAGO, Sept. 2, 2020 /PRNewswire/ -- The Blood Profiling Atlas in Cancer Consortium (BloodPAC) published "Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC's Analytical Variables Working...Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium
Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium
Top Membership Organizations Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bloodpac
BLOODPAC is a consortium focused on accelerating the development, validation, and accessibility of liquid biopsy assays to enhance cancer care and improve patient outcomes. Established in 2017, it fosters collaboration among stakeholders from industry, academia, and regulatory bodies to address challenges in the field of liquid biopsy. The consorti... Read More